GlassScriptPhysician profile
Alexandra Pellicena
NPI 1578564886
$851.82
in general payments reported to CMS, 2019-2025
16 companies · $50.14 in 2025
The $50.14 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $50.82 · 2021: $75.71 · 2022: $221 · 2023: $74.69 · 2024: $83.55 · 2025: $50.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $208.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $293.71 | 2019-2022 | |
| Astellas Pharma US INC | $193.28 | 2022-2024 | Veozah |
| Acessa Health INC. | $103.07 | 2019 | |
| Mayne Pharma Commercial LLC | $55.50 | 2021-2022 | |
| Hologic Sales and Service, LLC | $34.12 | 2025 | Aptima |
| Agile Therapeutics, INC. | $33.26 | 2022-2023 | Twirla |
| Aspira Women'S Health INC | $27.28 | 2024 | Ova1 |
| Myovant Sciences INC. | $25.53 | 2021 | |
| Avion Pharmaceuticals | $23.91 | 2020 | |
| Pfizer INC. | $18.16 | 2024 | |
| Shield Therapeutics INC | $16.02 | 2025 | |
| Coopersurgical, INC. | $14.77 | 2022 | |
| Horizon Therapeutics Plc | $13.21 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Pellicena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.